Ashwin Dharmadhikari
YOU?
Author Swipe
View article: Correlation of MADRS and YMRS in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study
Correlation of MADRS and YMRS in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study Open
Introduction Lumateperone, an atypical antipsychotic drug approved in 2021 for bipolar depression, has a dual mechanism of action by combination of activity at central serotonin (5-HT2A) and dopamine (D2) receptors. In India, Quetiapine is…
View article: Correlation of Q-LES-Q-SF and YMRS in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study
Correlation of Q-LES-Q-SF and YMRS in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study Open
Introduction Lumateperone, an atypical antipsychotic drug approved in 2021 for bipolar depression, has a dual mechanism of action by combination of activity at central serotonin (5-HT2A) and dopamine (D2) receptors. In India, Quetiapine is…
View article: Correlation of MADRS and Q-LES-Q-SF in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study
Correlation of MADRS and Q-LES-Q-SF in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study Open
Introduction Lumateperone, an atypical antipsychotic drug approved in 2021 for bipolar depression, has a dual mechanism of action by combination of activity at central serotonin (5-HT2A) and dopamine (D2) receptors. In India, Quetiapine is…
View article: Impact of Lumateperone compared to Quetiapine on MADRS in Indian patients with Bipolar II depression: A post-hoc analysis of a Phase 3 study
Impact of Lumateperone compared to Quetiapine on MADRS in Indian patients with Bipolar II depression: A post-hoc analysis of a Phase 3 study Open
Introduction Lumateperone, an atypical antipsychotic drug, has a dual mechanism of action by combination of activity at central serotonin (5-HT2A) and dopamine (D2) receptors. Objectives This post-hoc analysis of an Indian Phase 3 study wa…
View article: Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis
Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis Open
Multidrug-resistant tuberculosis (MDR-TB) threatens global TB control. The lengthy treatment includes one of the injectable drugs kanamycin, amikacin, and capreomycin, usually for the first 6 months. These drugs have potentially serious to…
View article: Contents
Contents Open
View article: Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment
Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment Open
View article: Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines
Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines Open
Upper room germicidal UV air disinfection with air mixing was highly effective in reducing tuberculosis transmission under hospital conditions. These data support using either a total fixture output (rather than electrical or UV lamp watta…